Clinical trialNCT02573714UnknownInterventional

Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises

SponsorCameroon Baptist Convention HealthEnrollment160Sickle Cell Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if the use of ketamine, sniffed in the nose, is a safe and effective way to help reduce pain in pediatric sickle cell patients with pain crises in resource-limited settings.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Ernest Nshom, MD
Cameroon Baptist Convention Health
Study Director
clinicaltrials.gov ↗
Hendry R Sawe, MD
Muhimbili University of Health and Allied Sciences
Study Director
clinicaltrials.gov ↗
James R Young, MD
Carolinas Medical Center
Principal Investigator
clinicaltrials.gov ↗
Juma Mfinanga, MD
Mihumbili National Hospital
Study Director
clinicaltrials.gov ↗
Michael Runyon, MD
Carolinas Medical Center
Study Chair
clinicaltrials.gov ↗
Stacy Reynolds, MD
Carolinas Medical Center
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Cameroon

Mbingo Baptist Hospital
Bamenda, Northwest Province, Cameroon
Ernest Nshom, MDEthan Helm, MD
Recruiting

Tanzania

Muhimbili National Hospital
Dar es Salaam, Tanzania
Hendry R Sawe, MDJuma Mfinanga, MD
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

KetamineNormal Saline

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2015
Primary completion: 31 Jul 2019
Completion: 31 Jul 2019
Last update posted: 14 Mar 2019
Registered enrollment: 160
Registry id: NCT02573714

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.